As we look back on 30 years since the discovery of BRCA1, here three women with faulty BRCA genes share their experiences of cancer. As we look back on 30 years since the discovery of BRCA1, here three women with faulty BRCA genes share their experiences of cancer.
9 October 2024
More than 40,000 people could benefit from a new oral hormone therapy for people with certain types of prostate cancer. More than 40,000 people could benefit from a new oral hormone therapy for people with certain types of prostate cancer.
19 July 2024
A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women. A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.
11 February 2022
Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.
19 September 2021
Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option. Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option.
14 September 2021
Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England. Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.
8 June 2021
A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer. A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer.
26 June 2020
A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time. A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.
20 January 2020
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial. Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.
1 June 2019
Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests. Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests.
30 April 2019
A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England. A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.
3 April 2019
The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England. The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.
7 June 2018
